CTRI/2020/12/029740已完成3 期
A multicentric, randomized, double blind, parallel, comparative study to demonstrate thenon-inferiority of fixed dose combination of Efonidipine 40 mg and S (-) Metoprolol 25 mgtablet to fixed dose combination of Cilnidipine 10 mg and Metoprolol 50 mg tablet in themanagement of hypertension.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients diagnosed with Stage-I hypertension (SBP/DBP: 140-159 / 90-99 mmHg) or Stage-II
- •hypertension (SBP/DBP: >= 160 / 100 mmHg).
- •2. Patients able to switch all prior antihypertensive medications safely to study medication (Investigatorâ??s discretion).
- •3. Patients willing to sign informed consent.
排除标准
- •1. Patients with known hypersensitivity to β-blockers or dihydropyridine calcium channel blockers.
- •2. Patients with history of severe, malignant or secondary hypertension.
- •3. Patient with cerebrovascular disease in the previous 3 months.
- •4. Patients with chronic arrhythmia, sick sinus syndrome or sinus bradycardia ( < 50 beats/min).
- •5. Patients with second- or third-degree atrioventricular block.
- •6. Women who are pregnant, lactating.
研究者
相似试验
已完成
3 期
Comparison of Efonidipine 40 mg and Chlorthalidone 12.5 mg combination tablets versus Cilnidipine 10 mg and Chlorthalidone 12.5 mg combination tablets in the management of high blood pressure.CTRI/2020/08/027364Zuventus Healthcare Limited240
已完成
3 期
A Phase III clinical study to compare efficacy and safety of Efonidipine and Telmisartan combination when compared to Cilnidipine and Telmisartan combination in patients with Stage II hypertension.CTRI/2020/12/029739Zuventus Healthcare Limited240
招募中
3 期
Clinical study to treat patients with peripheral neuropathic pain with coexistent Vitamin B12 deficiency with the help of FDC of Gabapentin SR plus Methylcobalamin plus Nortriptyline film-coated bilayered tablets.CTRI/2024/01/062148Ravenbhel Healthcare Pvt. Ltd.
尚未招募
3 期
A Study Metoprolol Succinate plus Cilnidipine plus Telmisartan Tablets in patients for treatment of uncontrolled essential hypertension with stable ischemic heart diseaseCTRI/2018/10/016182Ajanta Pharma Ltd
已完成
3 期
A Study of Combination of Azilsartan Medoxomil plus Cilnidipine Tablets for the treatment of subjects with Hypertension.CTRI/2019/07/020204Synokem Pharmaceuticals Ltd228